Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients

Posterior Reversible Encephalopathy Syndrome Clinical Trial

Official title: Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients

Status Recruiting

Clinical Trial Summary

Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Brain Diseases
• Critical Illness
• Posterior Reversible Encephalopathy Syndrome
• Syndrome

• NCT number: NCT03470467
• Study type: Observational [Patient Registry]
• Source: Ictal Group
• Contact: Stephane LEGRIEL, MD
• Phone: +33139639717
• Email: slegriel@ch-versailles.fr
• Status: Recruiting
• Start date: March 9, 2018
• Completion date: December 31, 2028